Blosozumab (Anti-SOST / Sclerostin)

Blosozumab (anti-SOST/ Sclerostin) is a humanized monoclonal antibody against sclerostin. Blosozumab stimulates bone formation, reduces bone resorption, and has the potential to be used in the research of osteoporosis. MW: 144.88 kD.
Supplier Selleck Chemicals
Product # A2787
Sku # A2787-1mg*5
Pricing 1mg*5, $970.00
Feedback